dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cedres Perez, Susana |
dc.contributor.author | Assaf, Juan David |
dc.contributor.author | Iranzo Gómez, Patricia |
dc.contributor.author | Callejo Perez, Ana |
dc.contributor.author | Pardo Aranda, Nuria |
dc.contributor.author | Navarro Mendivil, Alejandro |
dc.contributor.author | Martínez Marti, Alexandre |
dc.contributor.author | Marmolejo Castañeda, David |
dc.contributor.author | Rezqallah Aron, Maria Alejandra |
dc.contributor.author | Amat, Ramon |
dc.contributor.author | Pedrola Gómez, Anna |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Carbonell, Caterina |
dc.contributor.author | Frigola Rissech, Joan |
dc.contributor.author | Dienstmann, Rodrigo |
dc.date.accessioned | 2022-05-18T08:37:38Z |
dc.date.available | 2022-05-18T08:37:38Z |
dc.date.issued | 2021-11-01 |
dc.identifier.citation | Cedres S, Assaf JD, Iranzo P, Callejo A, Pardo N, Navarro A, et al. Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort. Sci Rep. 2021 Nov 1;11:21357. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/7550 |
dc.description | Teràpia del càncer; Mesotelioma |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mesotelioma - Tractament |
dc.subject | Pleura - Malalties - Tractament |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Mesothelioma |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Pleural Neoplasms |
dc.subject.mesh | Treatment Outcome |
dc.title | Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-00831-4 |
dc.subject.decs | mesotelioma |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | neoplasias pleurales |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-00831-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Cedres S, Assaf JD, Iranzo P, Callejo A, Pardo N, Navarro A, Martinez-Marti A, Marmolejo D, Rezqallah A] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Carbonell C, Frigola J, Amat R] Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pedrola A, Dienstmann R] Oncology Data Science (ODysSey Group), Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34725384 |
dc.identifier.wos | 000713727200034 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |